Report Detail
Global Nanopharmaceuticals Market Research Report 2020 by Manufacturers, Regions, Types and Applications
- RnM3855328 |
- 19 December, 2019 |
- Global |
- 122 Pages |
- XYZResearch |
- Pharma & Healthcare
In this report,global Nanopharmaceuticals Industry will reach 30.51 Billion USD by the end of 2021 with a CAGR of 13.04%
The global Nanopharmaceuticals Industry is valued at 14.63 Billion USD in 2015 and will reach 30.51 Billion USD by the end of 2021, growing at a CAGR of 13.04% during 2015-2021.
Nanopharmaceuticals are colloidal particles of 10 to 1,000 nanometers (1 micron) in size. They are widely used in drug delivery. Nanopharmaceuticals are diverse both in their shape and composition and often offer an advantage as compared to their “bulk” counterparts primarily because of size.
Nanopharmaceuticals can be divided into six categories: Liposomes type, Polymeric Micelles type, Solid lipid Nanoparticles type, Microemulsion & Nanoemulsion type, Nanosuspension type and other types. Liposomes type accounted for the highest proportion in revenue market, with a figure of 34.98% in 2015, followed by Polymeric Micelles type, account for 24.12% and Nanosuspension type account for 14.95%.
The sales market share of global Nanopharmaceuticals in Cancer and Tumor use, Autoimmune Disorders use, Inflammation use and other applications have been stable year by year, at 43.65%, 35.56%, 15.32% and 5.47% respectively in 2015, and for several consecutive years, the amplitude was within one percent. This indicates that the segment of the Nanopharmaceuticals in the global market tends to be fixed without great changes. Among them, the Nanopharmaceuticals Industry has the most promising sales prospects in Cancer and Tumor use.
XYZ research center data shows that USA is the biggest contributor to the Nanopharmaceuticals revenue market, accounted for 56.20% of the total global market with a revenue of 8.22 Billion USD in 2015, followed by Europe, 31.96% with a revenue of 4.67 Billion USD.
Merck is the largest company in the global Nanopharmaceuticals Industry, accounted for 16.84% of the revenue market share in 2015, followed by Pfizer and Novartis, accounted for 10.14% and 7.68% of the revenue market share in 2015. The top six producers account for above the half of the revenue market. Despite the presence of competition problems, due to the huge industry profits, investors are still optimistic about this area; there will be more investments to enter the field.
Geographically, global Nanopharmaceuticals market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Merck
Pfizer
Novartis
Abbott
GlaxoSmithKline
Roche
Sanofi
Eli Lilly
Astrazeneca
Johnson & Johnson
Celgene
Novavax
Stryker
Gilead Sciences
OSI Pharmaceuticals
Kadmon Pharmaceuticals
Samyang Biopharm
Mitsubishi Pharma
Kaken Pharmaceutical
Selecta Biosciences
Par Pharmaceutical
Cerulean Pharma
Navidea Biopharmaceuticals
Lummy
On the basis of product, we research the production, revenue, price, market share and growth rate, primarily split into
Liposomes
Polymeric micelles
Solid lipid nanoparticles
Microemulsion and nanoemulsion
Nanosuspension
For the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Nanopharmaceuticals for each application, including
Cancer and tumor
Autoimmune disorders
Inflammation
Others
Production, consumption, revenue, market share and growth rate are the key targets for Nanopharmaceuticals from 2014 to 2026 (forecast) in these regions
China
USA
Europe
Japan
Korea
India
Southeast Asia
South America
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
1 Report Overview
- 1.1 Definition
- 1.2 Manufacturers and Regions Overview
- 1.2.1 Manufacturers Overview
- 1.2.2 Regions Overview
- 1.3 Type Overview
- 1.4 Application Overview
- 1.5 Industrial Chain
- 1.5.1 Nanopharmaceuticals Overall Industrial Chain
- 1.5.2 Upstream
- 1.5.3 Downstream
- 1.5.4 Economic/Political Environment
2 Global Nanopharmaceuticals Market Assesment by Types
- 2.1 Overall Market Performance
- 2.1.1 Product Type Market Performance (Volume)
- 2.1.2 Product Type Market Performance (Value)
- 2.2 China Nanopharmaceuticals Market Performance
- 2.3 USA Nanopharmaceuticals Market Performance
- 2.4 Europe Nanopharmaceuticals Market Performance
- 2.5 Japan Nanopharmaceuticals Market Performance
- 2.6 Korea Nanopharmaceuticals Market Performance
- 2.7 India Nanopharmaceuticals Market Performance
- 2.8 Southeast Asia Nanopharmaceuticals Market Performance
- 2.9 South America Nanopharmaceuticals Market Performance
3 Global Nanopharmaceuticals Market Assesment by Application
- 3.1 Overall Market Performance (Volume)
- 3.2 China Nanopharmaceuticals Market Performance (Volume)
- 3.3 USA Nanopharmaceuticals Market Performance (Volume)
- 3.4 Europe Nanopharmaceuticals Market Performance (Volume)
- 3.5 Japan Nanopharmaceuticals Market Performance (Volume)
- 3.6 Korea Nanopharmaceuticals Market Performance (Volume)
- 3.7 India Nanopharmaceuticals Market Performance (Volume)
- 3.8 Southeast Asia Nanopharmaceuticals Market Performance (Volume)
- 3.9 South America Nanopharmaceuticals Market Performance (Volume)
4 Competitive Analysis
- 4.1 Merck
- 4.1.1 Merck Profiles
- 4.1.2 Merck Product Information
- 4.1.3 Merck Nanopharmaceuticals Production, Revenue, Price and Gross Margin
- 4.1.4 Merck Nanopharmaceuticals Business Performance
- 4.1.5 SWOT Analysis
- 4.2 Pfizer
- 4.2.1 Pfizer Profiles
- 4.2.2 Pfizer Product Information
- 4.2.3 Pfizer Nanopharmaceuticals Production, Revenue, Price and Gross Margin
- 4.2.4 Pfizer Nanopharmaceuticals Business Performance
- 4.2.5 SWOT Analysis
- 4.3 Novartis
- 4.3.1 Novartis Profiles
- 4.3.2 Novartis Product Information
- 4.3.3 Novartis Nanopharmaceuticals Production, Revenue, Price and Gross Margin
- 4.3.4 Novartis Nanopharmaceuticals Business Performance
- 4.3.5 SWOT Analysis
- 4.4 Abbott
- 4.4.1 Abbott Profiles
- 4.4.2 Abbott Product Information
- 4.4.3 Abbott Nanopharmaceuticals Production, Revenue, Price and Gross Margin
- 4.4.4 Abbott Nanopharmaceuticals Business Performance
- 4.4.5 SWOT Analysis
- 4.5 GlaxoSmithKline
- 4.5.1 GlaxoSmithKline Profiles
- 4.5.2 GlaxoSmithKline Product Information
- 4.5.3 GlaxoSmithKline Nanopharmaceuticals Production, Revenue, Price and Gross Margin
- 4.5.4 GlaxoSmithKline Nanopharmaceuticals Business Performance
- 4.5.5 SWOT Analysis
- 4.6 Roche
- 4.6.1 Roche Profiles
- 4.6.2 Roche Product Information
- 4.6.3 Roche Nanopharmaceuticals Production, Revenue, Price and Gross Margin
- 4.6.4 Roche Nanopharmaceuticals Business Performance
- 4.6.5 SWOT Analysis
- 4.7 Sanofi
- 4.7.1 Sanofi Profiles
- 4.7.2 Sanofi Product Information
- 4.7.3 Sanofi Nanopharmaceuticals Production, Revenue, Price and Gross Margin
- 4.7.4 Sanofi Nanopharmaceuticals Business Performance
- 4.7.5 SWOT Analysis
- 4.8 Eli Lilly
- 4.8.1 Eli Lilly Profiles
- 4.8.2 Eli Lilly Product Information
- 4.8.3 Eli Lilly Nanopharmaceuticals Production, Revenue, Price and Gross Margin
- 4.8.4 Eli Lilly Nanopharmaceuticals Business Performance
- 4.8.5 SWOT Analysis
- 4.9 Astrazeneca
- 4.9.1 Astrazeneca Profiles
- 4.9.2 Astrazeneca Product Information
- 4.9.3 Astrazeneca Nanopharmaceuticals Production, Revenue, Price and Gross Margin
- 4.9.4 Astrazeneca Nanopharmaceuticals Business Performance
- 4.9.5 SWOT Analysis
- 4.10 Johnson & Johnson
- 4.10.1 Johnson & Johnson Profiles
- 4.10.2 Johnson & Johnson Product Information
- 4.10.3 Johnson & Johnson Nanopharmaceuticals Production, Revenue, Price and Gross Margin
- 4.10.4 Johnson & Johnson Nanopharmaceuticals Business Performance
- 4.10.5 SWOT Analysis
- 4.11 Celgene
- 4.12 Novavax
- 4.13 Stryker
- 4.14 Gilead Sciences
- 4.15 OSI Pharmaceuticals
- 4.16 Kadmon Pharmaceuticals
- 4.17 Samyang Biopharm
- 4.18 Mitsubishi Pharma
- 4.19 Kaken Pharmaceutical
- 4.20 Selecta Biosciences
- 4.21 Par Pharmaceutical
- 4.22 Cerulean Pharma
- 4.23 Navidea Biopharmaceuticals
- 4.24 Lummy
5 Competitive Landscape
- 5.1 Global Nanopharmaceuticals Production (K Units) and Market Share by Manufacturers (2014-2020)
- 5.2 Global Nanopharmaceuticals Revenue (M USD) and Market Share by Manufacturers (2014-2020)
- 5.3 Global Nanopharmaceuticals Price (USD/Unit) of Manufacturers (2014-2020)
- 5.4 Global Nanopharmaceuticals Gross Margin of Manufacturers (2014-2020)
- 5.5 Market Concentration
6 Global Nanopharmaceuticals Market Assessment by Regions
- 6.1 Global Nanopharmaceuticals Production (K Units) and Market Share by Regions (2014-2020)
- 6.2 Global Nanopharmaceuticals Revenue (M USD) and Market Share by Regions (2014-2020)
- 6.3 Global Nanopharmaceuticals Price (USD/Unit) by Regions (2014-2020)
- 6.4 Global Nanopharmaceuticals Gross Margin by Regions (2014-2020)
7 Nanopharmaceuticals Regional Analysis
- 7.1 China Nanopharmaceuticals Production, Revenue and Growth Rate (2014-2020)
- 7.2 USA Nanopharmaceuticals Production, Revenue and Growth Rate (2014-2020)
- 7.3 Europe Nanopharmaceuticals Production, Revenue and Growth Rate (2014-2020)
- 7.4 Japan Nanopharmaceuticals Production, Revenue and Growth Rate (2014-2020)
- 7.5 Korea Nanopharmaceuticals Production, Revenue and Growth Rate (2014-2020)
- 7.6 India Nanopharmaceuticals Production, Revenue and Growth Rate (2014-2020)
- 7.7 Southeast Asia Nanopharmaceuticals Production, Revenue and Growth Rate (2014-2020)
- 7.8 South America Nanopharmaceuticals Production, Revenue and Growth Rate (2014-2020)
8 Global Nanopharmaceuticals Consumption Assessment
- 8.1 Global Nanopharmaceuticals Consumption and Market Share by Regions (2014-2020)
- 8.2 Global Nanopharmaceuticals Consumption Value and Market Share by Regions (2014-2020)
- 8.3 Global Nanopharmaceuticals Average Price (USD/Unit) by Regions (2014-2020)
9 Global Nanopharmaceuticals Sales Assessment by Regions
- 9.1 Global Nanopharmaceuticals Sales and Sales Value (2014-2020)
- 9.2 China Nanopharmaceuticals Sales and Sales Value (2014-2020)
- 9.3 USA Nanopharmaceuticals Sales and Sales Value (2014-2020)
- 9.4 Europe Nanopharmaceuticals Sales and Sales Value (2014-2020)
- 9.5 Japan Nanopharmaceuticals Sales and Sales Value (2014-2020)
- 9.6 Korea Nanopharmaceuticals Sales and Sales Value (2014-2020)
- 9.7 India Nanopharmaceuticals Sales and Sales Value (2014-2020)
- 9.8 Southeast Asia Nanopharmaceuticals Sales and Sales Value (2014-2020)
- 9.9 South America Nanopharmaceuticals Sales and Sales Value (2014-2020)
10 Technology and Cost
- 10.1 Technology
- 10.2 Cost
11 Channel Analysis
- 11.1 Market Channel
- 11.2 Distributors
12 Market Forecast 2021-2026
- 12.1 Production and Revenue Forecast 2021-2026
- 12.1.1 Global Nanopharmaceuticals Production and Revenue by Regions 2021-2026
- 12.1.2 China Nanopharmaceuticals Production, Revenue and Growth Rate 2021-2026
- 12.1.3 USA Nanopharmaceuticals Production, Revenue and Growth Rate 2021-2026
- 12.1.4 Europe Nanopharmaceuticals Production, Revenue and Growth Rate 2021-2026
- 12.1.5 Japan Nanopharmaceuticals Production, Revenue and Growth Rate 2021-2026
- 12.1.6 Korea Nanopharmaceuticals Production, Revenue and Growth Rate 2021-2026
- 12.1.7 India Nanopharmaceuticals Production, Revenue and Growth Rate 2021-2026
- 12.1.8 Southeast Asia Nanopharmaceuticals Production, Revenue and Growth Rate 2021-2026
- 12.1.9 South America Nanopharmaceuticals Production, Revenue and Growth Rate 2021-2026
- 12.2 Sales and Sales Value Forecast 2021-2026
- 12.2.1 Global Nanopharmaceuticals Consumption and Consumption Calue by Regions 2021-2026
- 12.2.2 Global Nanopharmaceuticals Sales and Sales Value Forecast 2021-2026
- 12.2.3 China Nanopharmaceuticals Sales, Sales Value and Growth Rate 2021-2026
- 12.2.4 USA Nanopharmaceuticals Sales and Sales Value Forecast 2021-2026
- 12.2.5 Europe Nanopharmaceuticals Sales and Sales Value Forecast 2021-2026
- 12.2.6 Japan Nanopharmaceuticals Sales and Sales Value Forecast 2021-2026
- 12.2.7 Korea Nanopharmaceuticals Sales and Sales Value Forecast 2021-2026
- 12.2.8 India Nanopharmaceuticals Sales and Sales Value Forecast 2021-2026
- 12.2.9 Southeast Asia Nanopharmaceuticals Sales and Sales Value Forecast 2021-2026
- 12.2.10 South America Nanopharmaceuticals Sales and Sales Value Forecast 2021-2026
- 12.3 Global Nanopharmaceuticals Production and Revenue Forecast by Type 2021-2026
- 12.3.1 Overall Market Performance
- 12.3.2 Liposomes
- 12.3.3 Polymeric micelles
- 12.3.4 Solid lipid nanoparticles
- 12.3.5 Microemulsion and nanoemulsion
- 12.3.6 Nanosuspension
- 12.4 Global Nanopharmaceuticals Sales Forecast by Application 2021-2026
- 12.4.1 Overall Market Performance
- 12.4.2 Cancer and tumor
- 12.4.3 Autoimmune disorders
- 12.4.4 Inflammation
- 12.4.5 Others
- 12.5 Global Nanopharmaceuticals Price and Gross Margin Forecast
- 13.5.1 Global Nanopharmaceuticals Averages Price Development Trend Forecast 2021-2026
- 13.5.2 Global Nanopharmaceuticals Gross Margin Development Trend Forecast 2021-2026
13 Conclusion
Summary:
Get latest Market Research Reports on Nanopharmaceuticals. Industry analysis & Market Report on Nanopharmaceuticals is a syndicated market report, published as Global Nanopharmaceuticals Market Research Report 2020 by Manufacturers, Regions, Types and Applications. It is complete Research Study and Industry Analysis of Nanopharmaceuticals market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
